S. 765 · 118th Congress
Reducing Hereditary Cancer Act of 2023
- Stage
- In committee
- Sponsor
- Lisa Murkowski
- Introduced
- 2023-03-09
- Latest action
- 2023-03-09 · Introduced in Senate
Summary
Reducing Hereditary Cancer Act of 2023
This bill provides for Medicare coverage of germline mutation testing for individuals with a personal or family history of a hereditary cancer gene mutation or suspected history of hereditary cancer, as well as for associated coverage of risk-reducing surgeries and screenings.